Clinical Trial Update: Continuous Glucose Monitoring (CGM) in Subjects With Type 2 Diabetes Taking Twice-Daily Exenatide or Once-Weekly Exenatide

View source ↗

Summary

This clinical trial update reports on continuous glucose monitoring use in subjects with Type 2 Diabetes Mellitus treated with either twice-daily exenatide or o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• BYETTA (Exenatide)
• Bydureon (exenatide)

Snippet

Sponsor: HealthPartners Institute | Conditions: Type 2 Diabetes Mellitus | Status: COMPLETED